Nabriva Therapeutics plc (NBRV) Declined -7.36% or -0.19 To Price $2.39 On Monday

Nabriva Therapeutics plc (NBRV) declined -7.36% or -0.19 to $2.39. It is nearly 947914 shares traded, which is 59.03% compare to the average total volume 1.61 million. The market cap of NBRV is $173.41 million. The year to date change is 46.21%. The 52 week price range is from $1.12 to $6.05. Price of NBRV have changed -1.15% during last week. It have changed -9.15% over last month, 25.85% over last 3 months, 32.31% over last 6 months and -43.05% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBRV is 2.69. It is 12.55% above current price. The 200-day Moving Averages for NBRV is 2.35. It is -1.67% below current price. The 52-week High is 6.05. It is 153.14% from the current price. The 52-week Low is 1.12. It is -53.14% from current price.

There are some statistics of NBRV. It is has market cap $173.41 million. The share outstanding is 72.56 million. The average volume is 1.61 million. The percent of top 15 Institution holding is 52.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBRV is -172.97%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBRV is -124.46%.


Share this post